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Abstract  Chronic  intestinal  pseudo-obstruction  (CIPO)  is  characterised  by  inadequate  diges-
tive tract  motility  and  can  lead  to  severely  disordered  motility.  CIPO  manifests  as  recurrent
episodes of  intestinal  sub-occlusion  without  an  anatomical  obstruction.  We  present  the  case
of a  41-year-old  female,  with  severe  chronic  constipation  and  several  episodes  of  intesti-
nal sub-occlusion.  Investigation  revealed  colonic  inertia  and  marked  distension  of  the  small
bowel and  colon  with  no  evidence  of  stenosis  or  obstructive  lesions,  compatible  with  CIPO.
After several  treatments  were  tried  (domperidone,  erythromycin,  cisapride,  octreotide,  total
enteral nutrition),  with  partial  or  no  response,  further  work-up  was  done  trying  to  identify
an etiology.  Gastrointestinal  manometry  showed  neuropathic  type  abnormalities,  transmural
biopsy of  the  jejunum  revealed  degenerative  enteric  neuropathy  and  anti-HU  antineuronal
antibody  screen  was  positive,  suggesting  an  autoimmune  type  neuropathy  with  diffuse  involve-
ment of  the  digestive  tract.  Corticosteroids  showed  partial  improvement  of  short  duration  and
azathioprine  was  also  tried  but  discontinued  due  to  intolerance.  Marked  dietary  intolerance
and malnutrition  lead  to  total  parenteral  nutrition  (TPN)  at  home  since  October  2011.  Since
then, symptoms  and  nutritional  status  improved,  with  rare  episodes  of  pseudo-obstruction,  not
requiring  hospitalisation.
©  2013  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
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Pseudo-obstruc¸ão  intestinal  crónica:  uma  manifestac¸ão  de  neuropatia  entérica
inﬂamatória
Resumo  Pseudo-obstruc¸ão  intestinal  crónica  (POIC)  caracteriza-se  por  motilidade  inadequada
do tubo  digestivo,  frequentemente  com  dismotilidade  severa.  Manifesta-se  por  episódios  recor-
rentes de  suboclusão  intestinal,  sem  obstruc¸ão  anatómica.  Apresentamos  o  caso  de  uma  mulher
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de  41  anos,  com  obstipac¸ão  crónica  severa  e  episódios  de  suboclusão  intestinal.  A  investigac¸ão
inicial revelou  inércia  cólica  e  distensão  marcada  do  intestino  delgado  e  cólon,  sem  lesões
obstrutivas, compatível  com  POIC.  Após  diversas  terapêuticas  (domperidona,  eritromicina,
cisapride,  octreótido,  nutric¸ão  entérica  total),com  eﬁcácia  parcial  ou  nula,  progrediu-se  na
investigac¸ão tentando  esclarecer  a  etiologia.  A  manometria  gastrointestinal  revelou  alterac¸ões
neuropáticas  e  uma  biopsia  transmural  jejunal  demonstrou  alterac¸ões  degenerativas  entéri-
cas. Estes  achados,  associados  á  presenc¸a  de  anticorpos  antineuronais  anti-HU,  sugeriam  uma
neuropatia  entérica  autoimune  atingindo  difusamente  o  tubo  digestivo.  Com  corticoterapia
obteve-se  melhoria  parcial  e  de  curta  durac¸ão  e  azatioprina  foi  tentada  mas  com  intolerân-
cia a  obrigar  á  sua  descontinuac¸ão.  Devido  ao  desenvolvimento  de  intolerância  alimentar
marcada,  associada  a  desnutric¸ão,  a  doente  está  sob  nutric¸ão  parentérica  total  domiciliária
desde 10/2011,  com  melhoria  signiﬁcativa  dos  sintomas  e  estado  nutricional,  raros  episódios
de pseudo-obstruc¸ão,  sem  necessidade  de  internamentos.
© 2013  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos
os direitos  reservados.
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oesogastric  junction,  oesophageal  manometry  results  were
compatible  with  achalasia.  The  dysphasia  resolved  after
endoscopic  dilatation  with  a  30  mm  Rigiﬂex  balloon.
Beginning  in  2009,  the  patient’s  clinical  status  progres-
sively  deteriorated,  with  frequent  episodes  of  sub-acute1. Introduction
Chronic  intestinal  pseudo-obstruction  (CIPO)  is  a  disorder
characterised  by  inadequate  digestive  tract  motility,  gener-
ally  due  to  poor  neuromuscular  function,  which  can  lead  to
severely  disordered  gastrointestinal  motility.1 The  condition
manifests  itself  as  recurrent  episodes  of  intestinal  sub-
occlusion,  clinically  similar  to  mechanical  obstruction,  but
without  the  presence  of  an  anatomical  obstruction.2 It  is
caused  by  a  disturbance  in  the  enteric  nervous  system  or
extrinsic  nervous  system  or  by  a  disorder  of  the  smooth
muscle  and  may  be  a  primary  disorder  (visceral  neurop-
athy  or  visceral  myopathy)  or  secondary  to  another  systemic
disorder.3 Oftentimes  the  aetiology  cannot  be  identiﬁed
and  is  considered  idiopathic  CIPO.  Diagnostic  assessment
includes  excluding  mechanical  obstruction  of  the  diges-
tive  tract,  documenting  dilatation  of  intestinal  segments,
determining  whether  other  segments  of  the  digestive  tract
besides  the  small  intestine  are  involved  and,  if  possible,
determining  the  aetiology.  Treatment  is  often  inadequate
but  is  aimed  at  improving  symptoms  and  ensuring  that  the
patient’s  nutritional  needs  are  adequately  met.
2. Clinical case report
Our  patient  was  a  41-year-old  female  with  Raynaud’s  phe-
nomenon,  with  no  relevant  history  or  family  history  of
digestive  disorders.  She  had  a  history  of  severe  constipa-
tion  since  the  age  of  29,  with  partial  response  to  laxatives.
Associated  with  the  constipation,  the  patient  experienced
episodes  of  marked  abdominal  distension,  abdominal  pain,
nausea  and  vomiting.  Abdominal  CT  done  during  one  of
these  episodes  revealed  marked  distension  of  the  colon
with  no  evidence  of  obstruction  (Fig.  1).  Further  work-up
done  since  then  showed:  upper  GI  study  was  normal;  small
bowel  transit  and  double  contrast  opaque  enema  studies
showed  marked  distension  of  the  jejunal  loops  and  of  the
colon,  with  no  evidence  of  stenosis  or  obstructive  lesions
(Figs.  2  and  3);  gastric  emptying  scintigraphy  was  compati-
ble  with  gastroparesis;  colonic  transit  time  was  compatible
with  colonic  inertia.  Based  on  this  clinical  picture  and  the
F
oxam  results,  a  diagnosis  of  CIPO  was  put  forward.  A  rectal
iopsy  ruled  out  amyloidosis.  The  patient  did  not  meet  the
riteria  for  conjunctive  tissue  disease.  In  2007  (at  36  years
f  age),  the  patient  began  to  experience  dysphagia  with
olid  foods  and  episodes  of  food  impaction.  Oesophageal-
astro-duodenal  transit  showed  reduced  distensibility  of  theigure  1  Abdominal  CT  during  an  episode  of  intestinal  sub-
cclusion.
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wigure  2  Double  contrast  opaque  enema  showing  colonic  dis-
ention  without  obstructive  lesions  or  stenosis.
ntestinal  obstruction  leading  to  multiple  hospitalisations
she  was  in  hospital  nearly  continuously  over  a  period  of  6
onths  in  2011),  with  a  weight  loss  of  15  kg  (BMI  --  17  kg/m2)
nd  malnutrition.  She  developed  complete  intolerance  to
egular  food  and  was  on  total  enteral  nutrition  for  approxi-
ately  2  years.  She  did  not  improve  with  domperidone,  had
nly  a  partial  temporary  response  to  erythromycin  and  later
o  cisapride,  nor  did  she  respond  to  octreotide.  The  hydro-
igure  3  Small  bowel  transit  showing  marked  distension  of
mall bowel  loops  without  obstructive  lesions  or  stenosis.
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en  breath  test  was  suggestive  of  bacterial  overgrowth,  so
he  patient  was  medicated  with  cycles  of  antibiotics,  but
howed  no  improvement.  In  2011  the  patient  underwent
astrointestinal  manometry,  which  showed  neuropathic  type
bnormalities.  An  electromyogram  with  dysautonomia  test
howed  no  evidence  of  peripheral  or  autonomic  neuropathy.
 transmural  biopsy  of  the  jejunum,  with  immunohistochem-
cal  testing,  revealed  degenerative  enteric  neuropathy  with
ligoneuronal  hypoganglionosis  of  the  myenteric  plexus;
o  changes  were  observed  in  the  muscle  layer.  An  anti-
U  antineuronal  antibody  screen  was  positive,  suggesting
hat  we  were  dealing  with  an  autoimmune  type  neurop-
thy  (after  paraneoplastic  syndrome  was  ruled  out)  with
iffuse  involvement  of  the  digestive  tract.  Although  it  is
nown  that  intestinal  failure  is  invariably  the  ﬁnal  stage  of
IPO,  because  of  the  ﬁndings  suggesting  autoimmunity  and
n  an  attempt  to  at  least  delay  progression  of  the  disease,
he  patient  was  treated  with  corticosteroids  (methylpred-
isolone  100  mg/day  IV  for  three  days  followed  by  oral
rednisolone,  with  gradual  tapering  of  the  dose  over  a  3-
onth  period).  Partial  improvement  of  short  duration  was
bserved.  The  patient  was  also  started  on  azathioprine
1.5  mg/kg/day),  but  this  was  discontinued  due  to  intoler-
nce.
Marked  dietary  intolerance  and  malnutrition  made  it
ecessary  to  put  the  patient  on  total  parenteral  nutrition
TPN)  at  home,  which  she  has  continued  since  October  2011
ith  no  complications  thus  far.  The  patient’s  symptoms
ave  improved,  with  rare  episodes  of  sub-acute  intesti-
al  obstruction  not  requiring  hospitalisation.  Her  nutritional
tatus  has  also  signiﬁcantly  improved  and  she  has  gained
eight  (current  weight  --  54  kg,  BMI  --  21  kg/m2).
. Discussion
IPO  is  the  most  severe  form  of  dysmotility  of  the  diges-
ive  tract,  which  is  a  failure  of  the  intestinal  contents  to
rogress  through  the  digestive  tract.3 Advances  in  func-
ional  studies  and  histological  analysis  have  enabled  a
etter  understanding  of  the  pathogenesis  of  this  syndrome,
hich  is  deﬁned  as  an  enteric  neuromuscular  disorder
hat  frequently  involves  various  segments  of  the  diges-
ive  tract  and  not  just  the  small  intestine.4 Based  on  the
attern  of  dysmotility  and  histopathologic  changes,  the
ondition  is  classiﬁed  as  visceral  neuropathy,  mesenchymal
isease  (involvement  of  the  interstitial  cells  of  Cajal)  or
isceral  myopathy.3 Visceral  neuropathies  can  be  inﬂam-
atory  or  degenerative.  Inﬂammatory  neuropathies  can  be
diopathic  or  secondary  (e.g.  infections,  paraneoplastic  syn-
rome)  and  are  characterised  by  the  presence  of  a  dense
ymphocytic  inﬁltrate  involving  the  myenteric  plexus  (gan-
lionitis)  causing  neuronal  degeneration.5 In  its  most  severe
orms,  complete  depletion  of  ganglion  cells  may  occur
aganglionosis).6 Enteric  ganglionitis  may  occur  throughout
he  digestive  tract  causing  severe  functional  damage.  Cases
f  CIPO  have  been  described  that  were  due  to  inﬂamma-
ory  neuropathy  associated  with  the  presence  of  anti-HU
ntineuronal  antibodies,  which  points  to  an  autoimmune
echanism.7,8 Screening  for  these  antibodies  is  recom-
ended  for  diagnosing  intestinal  dysmotility  associated  with
nteric  ganglionitis.5 Antineuronal  antibodies  may  be  asso-
ory  e
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ciated  with  a  paraneoplastic  syndrome  but  may  also  be
present  in  cases  of  idiopathic  CIPO.  Anti-Hu  antibodies  are
the  most  common  type  of  antineuronal  antibodies.  The  basis
of  pharmacological  treatment  is  immunosuppression,  using
corticosteroids  either  alone  or  in  combination  with  other
immunosuppressants,  such  as  azathioprine  or  cyclophos-
phamide,  described  with  variable  results.7,8 In  the  case  of
our  patient  gastrointestinal  manometry  revealed  a  pattern
consistent  with  enteric  neuropathy,  which,  in  combination
with  the  presence  of  antineuronal  antibodies,  suggested  the
possibility  that  we  were  dealing  with  an  autoimmune  enteric
neuropathy  (enteric  ganglionitis).  The  histologic  changes,
however,  showed  degenerative  neuropathy  with  oligoneu-
ronal  hypoganglionosis.  These  ﬁndings  could  be  explained  by
a  severe  inﬂammatory  process  diffusely  affecting  the  myen-
teric  plexus  that  occurred  in  the  past,  which  is  no  longer
present  but  which  led  to  severe  degeneration  with  gan-
glion  and  neuron  depletion.  This  hypothesis  may  explain  the
patient’s  poor  response  to  corticosteroids.
CIPO  causes  food  intolerance,  with  inadequate  food
intake,  and  malabsorption,  so  malnutrition  is  one  of  the
main  problems  and  therefore  nutritional  support  is  a  main-
stay  of  the  treatment.  Except  for  the  acute  episodes  of
pseudo  obstruction,  when  no  oral  intake  is  necessary  for  a
short  period,  whenever  possible  oral  feeding  (small  meals
and/or  enteral  nutritional  supplements)  is  advised,  because
is  better  tolerated  and  has  less  complications  than  total
parenteral  nutrition  (TPN).  TPN  is  reserved  for  the  most
severe  cases  (intestinal  failure),  as  the  only  way  to  satisfy
nutritional  requirements.  Nevertheless,  not  only  requires
adequate  education  and  training  of  the  patient  or  others
involved  in  handling  the  catheter,  but  also  is  associated
with  several  complications,  like  liver  disease,  pancreati-
tis,  glomerulonephritis  and  catheter-related  complications
(sepsis  and  thrombosis).  In  fact,  TPN-related  complications
are  one  of  the  main  causes  of  death  of  patients  with
CIPO.
For  these  reasons  we  tried  to  delay  the  introduction  of
home  TPN  for  as  long  as  the  patient  was  able  to  tolerate  the
enteral  nutritional  supplements  (liquid  supplements).  Dur-
ing  this  period  of  time  we  had  the  opportunity  to  get  more
informed  about  home  TPN,  educate  the  patient  about  hand-
ling  the  catheter,  about  the  risks  of  home  TPN  and  provide
adequate  social  conditions  and  nurse  support  at  home  for
this  type  of  nutritional  therapy.
Unfortunately,  this  patient’s  clinical  course  follows  the
usual  natural  history  of  the  disease,  with  progressive  wors-
ening  of  symptoms,  inconsistent  response  to  the  various
types  of  therapy  available,  ultimately  evolving  to  intestinal
failure.  Studies  on  the  natural  history  of  CIP  have  found  the
disorder  to  be  nearly  always  serious,  with  a  tendency  toward
progressive  worsening  of  symptoms.  Most  patients  exhibit
weight  loss  and  nutritional  deﬁciencies  due  to  limited  oral
intake  and  poor  absorption  associated  with  small  intestine
bacterial  overgrowth.  Approximately  33%  of  patients  end  up
on  home  TPN.9,10
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